Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor antigens Bfa5 for prevention and/or treatment of cancer

Tumor antigens Bfa5 for prevention and/or treatment of cancer

US Patent 8021664 · Granted Sep 20, 2011

Estimated economic value: $39,185,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2024
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy2022
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2021
Method for improving the efficacy of a survivin vaccine in the treatment of canc2020
Method for improving the efficacy of a survivin vaccine in the treatment of canc2018
Immunogenic compositions and related methods2017
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy2016
Immunogenic compositions2016
Replication-defective flavivirus vaccines and vaccine vectors2015
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer2015
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer2015
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer2015